Document Detail

Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: Prevalence and risk factors.
MedLine Citation:
PMID:  21936029     Owner:  NLM     Status:  Publisher    
BACKGROUND: Epidemiological and microbiological data suggest that Clostridium difficile infection (CDI) plays a substantial role in the clinical initiation of inflammatory bowel disease (IBD). The aim of the present study was to investigate the prevalence and risk factors of CDI in newly diagnosed pediatric patients with IBD. METHODS: The current investigation was a retrospective study. All patients newly diagnosed with IBD in the pediatric gastroenterology clinic in Warsaw between 2007 and 2010 were included in the present study. The patients were diagnosed according to Porto criteria and microbiology evaluation screening tests for CDI were conducted. Risk factors including prior hospitalization, use of antibiotics within 2 months of CDI detection, colonic involvement, and the duration of symptoms were evaluated. CDI diagnosis was based on a positive stool enzyme immunoassay. RESULTS: In the present study, 134 patients were evaluated (54 patients with Crohn's disease, and 80 with ulcerative colitis; 87% of the patients had colonic disease). The average age of the patients was 12.3 years, and the prevalence of CDI was 47% (95% confidence interval [CI], 38%-56%). Significant differences in the prevalence of CDI between patients with Crohn's disease and ulcerative colitis (P = 0.72; odds ratio [OR] = 1.187, 95% CI, 0.56-2.52) were not observed. The risk of CDI was associated with an increase in the age of the patient and the severity of the disease. CONCLUSIONS: The prevalence of CDI in newly diagnosed IBD patients was high and was independent of the type of disease. (Inflamm Bowel Dis 2011;).
Aleksandra Banaszkiewicz; Kinga Kowalska-Duplaga; Tomasz Pytrus; Hanna Pituch; Andrzej Radzikowski
Related Documents :
21937369 - Ultrasonography for leukocytosis or elevated c-reactive protein.
12635469 - Intravenous anti tnf-alpha antibody therapy leads to elevated triglyceride and reduced ...
22125559 - Arterial stiffness in female patients with fibromyalgia and its relationship to chronic...
21855519 - Clinical and electrocardiographic characteristics of patients with short qt interval in...
21859249 - Cryoglobulinemia in chronic hemodialysis patients.
21705259 - Levodopa ameliorated anorectal constipation in de novo parkinson's disease: the ql-gat ...
22807619 - Recurrent ischemic strokes in a young celiac woman with mthfr gene mutation.
14624769 - Evaluation of growth hormone stimulation tests in cured acromegalic patients.
22338649 - Prevalence and predictors of pulmonary embolism in korean patients with exacerbation of...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-20
Journal Detail:
Title:  Inflammatory bowel diseases     Volume:  -     ISSN:  1536-4844     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9508162     Medline TA:  Inflamm Bowel Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.
Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro.
Next Document:  Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: R...